HTLZF Stock
Price Chart
HTLZF Financial and Trading Overview
stock price | 1.59 |
Previous Close | 1.11 |
Open | 1.07 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 1.07 - 1.1 |
52 Week Range | 1.03 - 1.31 |
Volume | 5.6K |
Avg. Volume | 1.06K |
Market Cap | 160.69M |
Beta (5Y Monthly) | 0.538239 |
PE Ratio (TTM) | 55.000004 |
EPS (TTM) | 0 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
HTLZF Valuation Measures
Enterprise Value | 164.07M |
Trailing P/E | 55.000004 |
Forward P/E | 27.500002 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.6421669 |
Price/Book (mrq) | 2.7707808 |
Enterprise Value/Revenue | 2.698 |
Enterprise Value/EBITDA | 36.488 |
Trading Information
Stock Price History
Beta (5Y Monthly) | 0.538239 |
52-Week Change | 2.80% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.31 |
52 Week Low | 1.03 |
50-Day Moving Average | 1.19 |
200-Day Moving Average | 1.17 |
HTLZF Share Statistics
Avg. Volume (3 month) | 1.06K |
Avg. Daily Volume (10-Days) | 1.81K |
Shares Outstanding | 146.08M |
Float | 108.28M |
Short Ratio | N/A |
% Held by Insiders | 36.66% |
% Held by Institutions | 20.02% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 2.35% |
Operating Margin (ttm) | 3.95% |
Gross Margin | 50.43% |
EBITDA Margin | 7.39% |
Management Effectiveness
Return on Assets (ttm) | 1.87% |
Return on Equity (ttm) | 2.53% |
Income Statement
Revenue (ttm) | 60.82M |
Revenue Per Share (ttm) | 0.42 |
Quarterly Revenue Growth (yoy) | 18.80% |
Gross Profit (ttm) | 29.08M |
EBITDA | 4.5M |
Net Income Avi to Common (ttm) | 1.43M |
Diluted EPS (ttm) | 0.02 |
Quarterly Earnings Growth (yoy) | -86.099% |
Balance Sheet
Total Cash (mrq) | 15.89M |
Total Cash Per Share (mrq) | 0.11 |
Total Debt (mrq) | 17.81M |
Total Debt/Equity (mrq) | 30.75 |
Current Ratio (mrq) | 2.995 |
Book Value Per Share (mrq) | 0.397 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.41M |
Levered Free Cash Flow (ttm) | -358760 |
Profile of
Country | United States |
State | MA |
City | Beverly |
Address | 100 Cummings Centre |
ZIP | 01915 |
Phone | 978 921 2050 |
Website | https://www.hamiltonthorne.ltd |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, it manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as acts as a value-added reseller of a range of capital equipment and consumables. It sells its products and services through a direct sales force in the United States, Germany, France, Australia, Denmark, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.
Q&A For Stock
What is a current HTLZF stock price?
HTLZF stock price today per share is 1.59 .
How to purchase stock?
You can buy HTLZF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is HTLZF.
Which industry does the company belong to?
The industry is Medical Devices.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.